Publication Cover
Neurocase
Behavior, Cognition and Neuroscience
Volume 18, 2012 - Issue 5
225
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Treatment with levetiracetam in a patient with pervasive developmental disorders, severe intellectual disability, self-injurious behavior, and seizures: A case report

, , , &
Pages 386-391 | Received 13 Aug 2010, Accepted 05 Aug 2011, Published online: 07 Nov 2011
 

Abstract

Pervasive developmental disorder is characterized by various symptoms that often include self-injurious behavior (SIB). Episodes of SIB occur in the context of high emotional arousal, anger, or fear and may be related to epilepsy. We report the case of a 20-year-old man with pervasive developmental disorder presenting with SIB non-responsive to antipsychotic medication. Positron emission tomography showed a right temporoparietal hypometabolic focal lesion suggestive of an epileptic focus. Two weeks after initiation of levetiracetam (Keppra®), SIB disappeared, without recurrence 24 months later. Levetiracetam (Keppra®) may be beneficial for such patients.

Acknowledgments

We thank the nurse's team for the careful clinical observation, the patient's family for their availability, and the Fondation Handicap Mental et Societé for the encouragement provided. We also wish to thank Dr. G. Foletti and Dr. M. Seeck for their helpful advice, Mrs. Genevieve Nicoud for her support in bibliography, and Federico Carminati for technical assistance.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.